Precise Light addresses unmet needs for precision cutting and collateral damage control for endoscopic microsurgeries. Animal tests have yielded excellent results, human study begins this summer. It's 510(k) device with existing reimbursement, initially targeting a >$1B opportunity in ENT. We deliver better outcomes & safer procedures at a lower cost. Seeking $2m to complete the human study and to file 510(k) application, both within 9 months.